The differentiation of progressive supranuclear palsy

Nicholas J Cordato; Glenda M Halliday

doi:10.2217/nmt.15.37

The differentiation of progressive supranuclear palsy

Neurodegener Dis Manag. 2015 Oct;5(5):385-8. doi: 10.2217/nmt.15.37. Epub 2015 Oct 28.

Authors

Nicholas J Cordato^{1

2}, Glenda M Halliday²

Affiliations

¹ St George & Calvary Hospitals, 3 Chapel Street, Kogarah NSW 2217, Sydney, Australia.
² Neuroscience Research Australia & University of New South Wales, Sydney, Australia.

PMID: 26510162
DOI: 10.2217/nmt.15.37

No abstract available

Keywords: Parkinson's disease; Tau-protein; biomarkers; clinical differentiation; corticobasal degeneration; multiple system atrophy; neuroimaging; progressive supranuclear palsy.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Biomarkers*
Humans
Supranuclear Palsy, Progressive / diagnosis*
Supranuclear Palsy, Progressive / metabolism
Supranuclear Palsy, Progressive / pathology

Substances

Biomarkers